Update on Molecular Testing in von Willebrand Disease

Autor: Batlle, J, Perez-Rodriguez, A, Corrales, I, Borras, N, Pinto, JC, Lopez-Fernandez, MF, Vidal, F, Cid, AR, Bonanad, S, Parra, R, Mingot-Castellano, ME, Navarro, N, Altisent, C, Perez-Montes, R, Marcellini, S, Moreto, A, Herrero, S, Soto, I, Bernardo-Gutierrez, A, Mosteirin, NF, Jimenez-Yuste, V, Alonso, N, Jacob, AD, Fontanes, E, Campos, R, Paloma, MJ, Bermejo, N, Berrueco, R, Mateo, J, Arribalzaga, K, Marco, P, Palomo, A, Quismondo, NC, Inigo, B, Nieto, MD, Vidal, R, Martinez, MP, Aguinaco, R, Tenorio, M, Ferreiro, M, Garcia-Frade, J, Rodriguez-Huerta, AM, Cuesta, J, Rodriguez-Gonzalez, R, Garcia-Candel, F, Dobon, M, Aguilar, C, Bastida, JM, Nunez, R, Aguirre, MA, Rodriguez-Luaces, M, Gordillo, M, de Cos, C, Torres, L, Batlle, F, PCM-EVW-ES Investigators Team

Publikováno v: SEMINARS IN THROMBOSIS AND HEMOSTASIS
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Diagnosis of von Willebrand disease (VWD) depends on personal and family history of bleeding and confirmatory laboratory testing. Currently available phenotypic tests for VWD contain potential sources for error that may distort results. Despite an ex

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::1a0a0f43f3b197384952fc4be42c1d84
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=14316

The prothrombin time/international normalized ratio (PT/INR) Line: derivation of local INR with commercial thromboplastins and coagulometers – two independent studies

Autor: POLLER L, IBRAHIM S, KEOWN M, PATTISON A, JESPERSEN J, EUROPEAN ACTION ON A.N.T.I.C.O.A.G.U.L.A.T.I.O.N. COLLABORATORS: MARUN S, MUNTEAN W, ASPÖCK G, BAILLEUL E, WIJNS W, MICHEL T, JOCHMANS K, CHATELAIN B, MARCELIS L, NIJS AN, JOHNSTON M, KYNDE K, SYRÄJLÄ M, SAVOLAINEN ER, IVASKA K, RAJAMÄKI A, VANHARANTA R, JUHAN I, AILLAUD MF, GUILLIN MC, HUISSE MG, SIE P, LECOMPTE T, SCHMITT Y, HARENBERG J, PLESCH W, ARONIS S, THEODOSSIADES G, TSOUKANAS B, MARKALA D, DITSA M, CAHILL M, MADDEN M, FITZGERALD H, MCCARTHY D, COLLINS B, ROONEY S, NAPARSTEK E, MARONGIU F, ERBA N, TESTA S, MARIANI G, POTÌ R, MANNUCCI PM, TRIPODI A, BADER R, PENGO V, GRESELE P, D'INCÀ M, AGENO W, TOSETTO A, HENSGENS HE, IDEMA RN, OOSTERHOUT DH, MULDER AB, HAMULYAK K, VD DUSSEN H, MUSIAL J, GAGO T, PALMEIRO A, CAMPOS M, MARQUES DIAS DA, CUNHA MONTEIRO Á, ANGELA CUNHA M, DE GAIA WN, PETERNEL P, STEGNAR M, FONTCUBERTA J, BORRELL M, REVERTER JC, SANTASUSANA PD, LOPEZ FERNANDEZ MF, MONTERO J, RIBERA CASADO C, VICENTE V, EDLUND B, EGBERG N, LÄMMLE B, ALBERIO L, DE MOERLOOSE P, REBER G, MACHIN SJ, MACKIE I, LAWRIE A, LUCKIT J, SHANKS D, DOLAN G, FLAHERTY T, LUDLAM CA, WALKER ID, LAWSON DE, TRISCOTT M, MARLAR RA, HEIT JA, WATZKE H, WEISSER B, GALLUS AS, OSMOND J, CORNET I, MUNSTER AM, LEED B, CHILLOU C, DEFARD M, HORELLOU MH, HALKIN H, LOEBSTEIN R, KIRGNER I, DENTALI F, TRAPANI LOMBARDO V, SOTTILOTTA G, CONSIGLIO P, DE MICHELE S, MOIA M, CARPENEDO M, OLIVIERO B, MANOTTI C, TASSONI MI, PALARETI G, BRUSI C, LEGNANI C, PEGORARO C, ANDRIANI C, GRAZIA CIRIGLIANO M, RIBALDI E, ABBATE R, POLI D, PERRICONE C, SCHIAVULI M, CASIERA C, LUPONE MR, ROSSI E, CRIVELLI S, BIROLINI A, PARENTE F, MIGLIETTA AM, CAMPOBASSO M, SYDOR W, KREVEL B, FERNANDEZ MA, LOZANO M, SHIACH C, BOWYER C, CHARLES F., PALARETI, GUALTIERO, COSMI, BENILDE

Publikováno v: European Action on Anticoagulation (EAA) & Münster, A-M B 2011, ' The prothrombin time/international normalised ratio (PT/INR) line: derivation of local INR with commercial thromboplastins and coagulometers – two independent studies ', Journal of Thrombosis and Haemostasis, vol. 9, no. 1, pp. 140-148 . https://doi.org/10.1111/j.1538-7836.2010.04109.x
Journal of Thrombosis and Haemostasis, 9(1), 140-148. Wiley

The WHO scheme for prothrombin time (PT) standardization has been limited in application, because of its difficulties in implementation, particularly the need for mandatory manual PT testing and for local provision of thromboplastin international ref

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4033b274d27f3fdad18dfdd3b426609a
https://doi.org/10.1111/j.1538-7836.2010.04109.x

Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors

Autor: Mingot-Castellano, ME, Alvarez-Roman, MT, Lopez-Fernandez, MF, Altisent-Roca, C, Canaro-Hirnyk, MI, Jimenez-Yuste, V, Cid-Haro, AR, Perez-Garrido, R, Sedano-Balbas, C

Publikováno v: EUROPEAN JOURNAL OF HAEMATOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

IntroductionPatients with severe haemophilia and inhibitors against factor VIII who require surgery need a prophylactic approach to prevent bleeding complications. Scientific evidence to decide the best prophylactic treatment is very limited and main

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::fd729e149bbbaa3dda5329d776636e04
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9223

Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study).

Autor: Rocino, A., Cortesi, P. A., Scalone, L., Mantovani, L. G., Crea, R., Gringeri, A., Altisent, C, Astermark, J, Diniz, MJ, Fijnvandraat, K, Klamroth, R, Lambert, T, Lavigne‐Lissalde, G, Lopez‐Fernandez, MF, Morfini, M

Publikováno v: Haemophilia; Jan2016, Vol. 22 Issue 1, p96-102, 7p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.